Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
Clinical trial NCT02939599 · TERMINATED
Trial details
- NCT number
- NCT02939599
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2018-11-06
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.